Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ridgetech's revenue per share for the
six
months ended in Mar. 2026 was €566.00.
Ridgetech's revenue per share for the trailing twelve months (TTM) ended in Mar. 2026 was €1,938.05.
Warning Sign:
Ridgetech Inc revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue Per Share Growth Rate of Ridgetech was -44.20% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was -64.40% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was -62.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Ridgetech's Revenue per Share or its related term are showing as below:
FRA:7QL'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -73 Med: -30.1 Max: 15.2
Current: -64.4
During the past 13 years, Ridgetech's highest 3-Year average Revenue Per Share Growth Rate was 15.20% per year. The lowest was -73.00% per year. And the median was -30.10% per year.
FRA:7QL's 3-Year Revenue Growth Rate is ranked worse than 99.02% of 610
companies
in the Healthcare Providers & Services industry
Industry Median: 7
vs FRA:7QL: -64.40
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Ridgetech Revenue per Share Related Terms
Ridgetech Revenue per Share Historical Data
* Premium members only.
The historical data trend for Ridgetech's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:7QL vs BLMH, DHTI, HEWA: Revenue per Share Comparison
For the Pharmaceutical Retailers subindustry, Ridgetech's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ridgetech PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ridgetech's PS Ratio distribution charts can be found below:
* The bar in red indicates where Ridgetech's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Ridgetech's Revenue Per Share for the fiscal year that ended in Mar. 2026 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1,938.05
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ridgetech (FRA:7QL) has a Revenue per Share of €1,938.05 as of Mar. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on Ridgetech and its competitors. According to the industry distribution chart, Ridgetech ranks #604 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 99%.
Is Ridgetech's Revenue per Share too high?
Ridgetech's current Revenue per Share is €1,938.05. Based on the distribution chart, Ridgetech ranks #604 out of 610 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ridgetech has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Ridgetech's Revenue per Share compare to BLMH and DHTI?
According to the Healthcare Providers & Services industry distribution chart, Ridgetech ranks #604 out of 610 companies for Revenue per Share. This places Ridgetech in the lower half of its industry. The industry median Revenue per Share is 7.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Healthcare Providers & Services company?
The median Revenue per Share among Healthcare Providers & Services companies is 7.00, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Ridgetech and its competitors. For the Healthcare Providers & Services industry, the median Revenue per Share is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ridgetech's current Revenue per Share is €1,938.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ridgetech stock overvalued right now?
Ridgetech (FRA:7QL) has a current Revenue per Share of €1,938.05. The stock's GF Value™ is €1,269,956.62, compared to a current price of €20,304.00 — trading 98.4% below its estimated fair value. The current Revenue per Share is €1,938.05. Ridgetech's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Ridgetech (FRA:7QL), the current Revenue per Share is €1,938.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ridgetech (FRA:7QL) Overvalued in 2026?
Based on GuruFocus' analysis, Ridgetech stock appears to be undervalued.
The current stock price of €20,304.00 is trading 98.4% below its estimated GF Value™ of €1,269,956.62.
Key valuation signals for FRA:7QL:
Revenue per Share: €1,938.05
GF Value™: €1,269,956.62 vs. price of €20,304.00 (98.4% below fair value)
No single metric tells the full story. See the FRA:7QL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
39GF Score
Get the complete analysis for FRA:7QL
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7QL has been successfully added to your 
